For instance, transforming growth factor beta (TGF-β) which is elevated in metastatic breast cancer patients, can directly suppresses NK cell metabolism through both mTORC1 inhibition and mTORC1-independent inhibition of mitochondrial metabolism [35–37]. Here, TGFB1 is linked to breast carcinoma.